Neuropathy is a common complication of diabetes, causing discomfort and disability in many patients with diabetes. In animal models of the disease. Specific defects in retrograde axonal transport and in slow anterograde axonal transport occur early after the induction of diabetes. The link between reduced retrograde transport and the known metabolic abnormalities of hyperglycemia, nerve sorbitol accumulation, or nerve myoinositol depletion is not known. Neither has the mechanism underlying slowed anterograde axonal transport of neurofilaments (and the associated structural alterations) been identified. We intend to investigate the mechanisms responsible for the alterations in order to define the alterations in axonal biology that cause neuropathy. We propose to study three specific questions. 1. Can the reductions in retrograde transport be reversed by aldose reductase inhibition or dietary myo-inositol supplementation? 2. Are alterations in the transport of neurofilaments caused by alterations in the post-transnational modification and/or in situ degradation of neurofilaments mediated by calcium activated neutral proteases? 3. Are there specific alterations in the intra-axonal distribution of calcium in the nerve in diabetes? We will use the 3H NSP method to measure retrograde axonal transport in rats with STZ diabetes, and determine whether treatment with sorbinil or dietary supplementation with myo- inositol reverses the defect in retrograde transport we have identified. We will use in-vitro assays to measure the post- transnational modification and degradation of neurofilaments by endogenous protease activated by micromolar Ca++ in normal and diabetic rats. We will measure the activity of that enzyme with an.exogenous substrate to determine whether reduced protease activity is due to reduced enzyme activity or increased inhibitor. We will use the oxalate pyroantimonate method to identify the ultrastructural distribution of calcium in the nerve of diabetic rats. The results of these studies should allow insight into the pathogenesis of diabetic neuropathy, as well as into the biochemical mechanisms involved in axonal transport in normal nerve.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29NS027771-05
Application #
2266584
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1989-01-01
Project End
1994-12-31
Budget Start
1993-01-01
Budget End
1994-12-31
Support Year
5
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Neurology
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Fink, D J; Fang, D; Li, T et al. (1995) Na,K-ATPase beta subunit isoform expression in the peripheral nervous system of the rat. Neurosci Lett 183:206-9
Fink, D J; Datta, S; Mata, M (1994) Isoform specific reductions in Na+,K(+)-ATPase catalytic (alpha) subunits in the nerve of rats with streptozotocin-induced diabetes. J Neurochem 63:1782-6
Mata, M; Datta, S; Jin, C F et al. (1993) Differential axonal transport of individual Na,K-ATPase catalytic (alpha) subunit isoforms in rat sciatic nerve. Brain Res 618:295-8
Mata, M; Jin, C F; Fink, D J (1993) Axotomy increases CNTF receptor mRNA in rat spinal cord. Brain Res 610:162-5
Mata, M; Kupina, N; Fink, D J (1992) Phosphorylation-dependent neurofilament epitopes are reduced at the node of Ranvier. J Neurocytol 21:199-210
Mata, M; Kupina, N; Fink, D J (1991) Calpain II in rat peripheral nerve. Brain Res 564:328-31
Mata, M; Siegel, G J; Hieber, V et al. (1991) Differential distribution of (Na,K)-ATPase alpha isoform mRNAs in the peripheral nervous system. Brain Res 546:47-54
Mata, M; Fink, D J; Ernst, S A et al. (1991) Immunocytochemical demonstration of Na+,K(+)-ATPase in internodal axolemma of myelinated fibers of rat sciatic and optic nerves. J Neurochem 57:184-92